Topic: artificial intelligence
Google’s AI reached a milestone in lung cancer imaging, diagnosing cases from CT scans as well as or better than a group of six radiologists.
A new, promising data source that could help explore and unlock new discoveries lies in the use of simulated data that can be used in place of real patient information.
To make clinical trials more affordable and lead to the results needed for approval, MarkLogic has set up a new hub designed to do just that.
Zebra Medical received an FDA go-ahead to use AI to quickly scour X-rays and alert clinicians for signs of pneumothorax.
Janssen has become the latest Big Pharma to delve deeper into AI's potential to boost the number of successful drugs coming through the pipeline.
As Philips transitions toward an integrated service provider, it aims to use AI to help shepherd patients from consumer health to the clinic and back.
AI in drug development is among the hottest buzzwords in biopharma right now, but real progress is hampered by lack of expertise and access.
The web-based solution detects and classifies the sounds of potentially dangerous heart murmurs using a digital stethoscope.
AstraZeneca tapped BenevolentAI to help bring artificial intelligence and machine learning to its drug discovery projects aimed at CKD and IPF.
Toronto-based Future Fertility is using an artificial intelligence-based tool to objectively measure egg quality and improve the success rate of IVF.